Healthstream (HSTM) FY2014 results: revenue $171 million, up 29.0% on the year
Healthstream Inc. (HSTM) reported revenue of $171 million for fiscal 2014, the year ended 31 December 2014, up 29.0% on the year before. Net income was $10 million, up 23.5%, and diluted earnings per share $0.37. The figures are the company's own, from the 10-K it filed with the SEC on 27 February 2015.
Revenue
$171 million
+29.0% on the year
FY2009FY2014
Operating margin
9.6%
11.1% a year earlier
FY2009FY2014
Net income
$10 million
+23.5% on the year
FY2009FY2014
Diluted EPS
$0.37
+23.3% on the year
FY2009FY2014
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Revenue
171
132
104
+29.0%
Cost of revenue
n/a
n/a
41.7
Gross profit
n/a
n/a
62.1
Gross margin
n/a
n/a
59.8%
Research and development
16.5
11.8
8.6
+40.0%
Operating income
16.4
14.7
13.5
+11.7%
Operating margin
9.6%
11.1%
13.0%
Pre-tax income
16.5
14.8
13.6
+11.3%
Income tax
6.1
6.4
5.9
-4.6%
Effective tax rate
37.1%
43.3%
43.7%
Net income
10.4
8.4
7.6
+23.5%
Net margin
6.1%
6.4%
7.4%
Diluted EPS
$0.37
$0.30
$0.28
+23.3%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Operating cash flow
34.3
26.3
22.5
+30.3%
Capital expenditure
4.5
4.4
4.3
+2.3%
Free cash flow
29.7
21.8
18.2
+36.1%
Free cash flow margin
17.4%
16.5%
17.5%
Cash from investing
n/a
-15.0
-59.0
Cash from financing
n/a
6.9
0.9
Depreciation and amortisation
10.9
7.9
6.7
+39.2%
Share-based compensation
1.6
1.5
1.1
+11.5%
Diluted shares, weighted
28m
28m
28m
+1.3%
Shares outstanding at period end
28m
27m
26m
+1.3%
Balance sheet
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Shareholders' equity
168
149
132
+12.3%
Debt
0.0
0.0
0.0
Other liabilities
89.4
63.2
42.3
+41.5%
Total liabilities and equity
257
213
175
+21.0%
Fixed assets
9.4
9.0
7.8
+4.5%
Goodwill
41.9
35.7
29.3
+17.3%
Intangible assets
14.8
8.9
8.8
+66.8%
Investments
39.0
n/a
52.0
Cash and equivalents
82.0
59.5
41.4
+37.7%
Receivables
33.2
25.3
15.3
+31.0%
Other assets
37.0
74.1
19.9
-50.1%
Total assets
257
213
175
+21.0%
10-K for the year ended 31 December 2014, filed 27 February 2015: the filing.